Phase 3 trial shows lurbinectedin plus atezolizumab significantly improves progression-free and overall survival in ES-SCLC ...

Final OS results from INAVO120 show inavolisib plus palbociclib and fulvestrant significantly improves survival, delays ...

Vepdegestrant, an oral PROTAC, nearly doubles progression-free survival in ESR1-mutated, ER-positive advanced breast cancer, ...

Children with chronic or life-limiting conditions face high hospitalization rates, ICU use, and in-hospital mortality, ...

This is the first real-world evidence that expanded prophylactic antibiotic use can reduce community transmission of iGAS.

The findings support the concept that excessive lipogenesis, rather than just fat delivery from other sources, is central to ...

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis ...

These real-world results support the effectiveness of maternal RSV vaccination and could influence policy decisions in other ...

Discover more about how, once inhaled or ingested, microplastics can lodge in human tissues, including the lungs, blood, and ...

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the ...

This systematic review reveals limited evidence supporting current interventions for fatigue in pediatric rheumatic diseases, ...

A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited ...